Fundraising Fox

OWP Pharmaceuticals

Naperville, US · Illinois corporation

Find your way into OWP Pharmaceuticals

8 people in our graph share verified history with the OWP Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.

Morgan Odellunlockedknows Scott Boyer · together at Inventiv Health (overlapped)
×6knows the team · via Inventiv Health
knows the team · via Morningside University

OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company that develops and markets branded generic and generic lamotrigine Starter Kits (Subvenite) for epilepsy and bipolar disorder in the U.S. Operating as a social enterprise, it donates profits to the ROW Foundation to support treatment of neurological disorders in under-resourced regions.

BiotechHealthtechImpact & Social Good

Founders & leadership

SBScott Boyer
Scott BoyerinFounder and PresidentScott Boyer is Founder and President of OWP Pharmaceuticals, a specialty pharmaceutical company that commercializes neuroscience products in the U.S., and founded the associated ROW Foundation, which provides educational, diagnostic, and treatment resources for neurological disorders in under-resourced regions globally.
SBSTEVE BOURNE
STEVE BOURNEinChief Financial Officer

Board

CG
CAROL GAVINBoard director
KF
KURT FLORIANBoard director
PR
PAUL REGANBoard director
TH
TROY HAMMONDBoard director
BD
BRUCE DUNCANBoard director

Reported raises · per SEC filings

Form D private placements

$5.1M disclosed across 2 rounds · 2024–2025

▶$2.4MraisedSep 2025 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • TROY HAMMONDDirector
  • STEVE BOURNEExecutive Officer
  • MATT LITFINDirector
  • KURT FLORIANDirector
  • SCOTT BOYERExecutive Officer, Director
  • BRUCE DUNCANDirector
Offering amount
$2.4M
Amount sold
$2.4M
Minimum investment
$25K
First sale
Jul 2025
Incorporated
Corporation, Illinois
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedSep 2024 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • STEVE BOURNEExecutive Officer
  • CAROL GAVINDirector
  • SCOTT BOYERExecutive Officer, Director
  • KURT FLORIANDirector
  • PAUL REGANDirector
  • TROY HAMMONDDirector
  • BRUCE DUNCANDirector
Offering amount
$2.7M
Amount sold
$2.7M
Minimum investment
$25K
First sale
Jun 2024
Incorporated
Corporation, Illinois
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Walgreens6 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Bionpharma5 shared keywordsBionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules. It also sells OTC products online through its A+ Health brand on Amazon.

Companies competing with OWP Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

OWP Pharmaceuticals announces drug's FDA approvaldailyherald.com · Nov 2021FAQs | OWP Pharmaceuticalsowppharma.com · Apr 2021

Frequently asked questions

What does OWP Pharmaceuticals do?
OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company that develops and markets branded generic and generic lamotrigine Starter Kits (Subvenite) for epilepsy and bipolar disorder in the U.S. Operating as a social enterprise, it donates profits to the ROW Foundation to support treatment of neurological disorders in under-resourced regions.
Who founded OWP Pharmaceuticals?
OWP Pharmaceuticals was founded by Scott Boyer.
How much funding has OWP Pharmaceuticals raised?
OWP Pharmaceuticals has disclosed $5.1M raised across 2 rounds.
Where is OWP Pharmaceuticals headquartered?
OWP Pharmaceuticals is headquartered in Naperville, US.